Deep Dive Into Hims & Hers Health Stock: Analyst Perspectives (8 Ratings)
Portfolio Pulse from Benzinga Insights
Hims & Hers Health (NYSE:HIMS) has received varied analyst ratings over the past three months, with a mix of bullish and indifferent sentiments. Analysts have set a 12-month average price target of $21.75, indicating a 31.26% increase from the previous target. The company has shown strong financial performance, with significant revenue growth and profitability metrics exceeding industry averages.

September 13, 2024 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Hims & Hers Health has received a mix of bullish and indifferent analyst ratings, with a 12-month average price target of $21.75, reflecting a 31.26% increase. The company shows strong financial performance with high revenue growth and profitability.
The article highlights a positive trend in analyst price targets for HIMS, with a significant increase from previous targets. The company's strong financial metrics, such as high revenue growth and profitability, support a positive short-term outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100